36 related articles for article (PubMed ID: 18357388)
1. ATR alterations in Hodgkin's lymphoma.
Liu A; Takakuwa T; Fujita S; Luo WJ; Tresnasari K; Van den Berg A; Poppema S; Aozasa K
Oncol Rep; 2008 Apr; 19(4):999-1005. PubMed ID: 18357388
[TBL] [Abstract][Full Text] [Related]
2. Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
[TBL] [Abstract][Full Text] [Related]
3. Alterations of DNA damage-response genes ATM and ATR in pyothorax-associated lymphoma.
Liu A; Takakuwa T; Fujita S; Ham MF; Luo WJ; Daibata M; Aozasa K
Lab Invest; 2005 Mar; 85(3):436-46. PubMed ID: 15696190
[TBL] [Abstract][Full Text] [Related]
4. Single-cell analysis of loss of heterozygosity at the ATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma: ATM loss of heterozygosity is a rare event.
Lespinet V; Terraz F; Recher C; Campo E; Hall J; Delsol G; Al Saati T
Int J Cancer; 2005 May; 114(6):909-16. PubMed ID: 15645496
[TBL] [Abstract][Full Text] [Related]
5. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
[TBL] [Abstract][Full Text] [Related]
6. Aberrant and multiaberrant (rogue) cells in peripheral lymphocytes of Hodgkin's lymphoma patients after chemotherapy.
Ryabchenko NI; Nasonova VA; Fesenko EV; Kondrashova TV; Antoschina MM; Pavlov VV; Ryabikina NV
Mutat Res; 2006 Oct; 601(1-2):61-70. PubMed ID: 16828123
[TBL] [Abstract][Full Text] [Related]
7. Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib.
Jun HJ; Kim YM; Park SY; Park JS; Lee EJ; Choi SA; Pyo H
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):225-34. PubMed ID: 19695440
[TBL] [Abstract][Full Text] [Related]
8. [Global gene expression analysis and novel signalling pathways in Hodgkin lymphoma].
Bräuninger A; Renné C; Willenbrock K; Martin-Subero JI; Hinsch N; Tiacci E; Siebert R; Küppers R; Hansmann ML
Verh Dtsch Ges Pathol; 2006; 90():136-41. PubMed ID: 17867590
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of Hodgkin's lymphoma.
Re D; Küppers R; Diehl V
J Clin Oncol; 2005 Sep; 23(26):6379-86. PubMed ID: 16155023
[TBL] [Abstract][Full Text] [Related]
10. p53 Expression as a prognostic indicator in Hodgkin's lymphoma.
Spector N; Milito CB; Biasoli I; Morais JC
J Clin Oncol; 2005 May; 23(13):3158-9; author reply 3159-60. PubMed ID: 15860883
[No Abstract] [Full Text] [Related]
11. Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells.
Braune K; Volkmer I; Staege MS
PLoS One; 2017; 12(1):e0170694. PubMed ID: 28135309
[TBL] [Abstract][Full Text] [Related]
12. P53 gene alterations identified in classical Hodgkin's lymphoma cell lines.
Maki CG
Leuk Lymphoma; 2006 Sep; 47(9):1734-5. PubMed ID: 17064981
[No Abstract] [Full Text] [Related]
13. The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles.
Chevarin M; Alcantara D; Albuisson J; Collonge-Rame MA; Populaire C; Selmani Z; Baurand A; Sawka C; Bertolone G; Callier P; Duffourd Y; Jonveaux P; Bignon YJ; Coupier I; Cornelis F; Cordier C; Mozelle-Nivoix M; Rivière JB; Kuentz P; Thauvin C; Boidot R; Ghiringhelli F; O'Driscoll M; Faivre L; Nambot S
Oncotarget; 2023 Feb; 14():111-125. PubMed ID: 36749285
[TBL] [Abstract][Full Text] [Related]
14. Genetic lesions and targeted therapy in Hodgkin lymphoma.
Li Z; Mu W; Xiao M
Ther Adv Hematol; 2023; 14():20406207221149245. PubMed ID: 36654739
[TBL] [Abstract][Full Text] [Related]
15. Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series.
Scott AJ; Tokaz MC; Jacobs MF; Chinnaiyan AM; Phillips TJ; Wilcox RA
Fam Cancer; 2021 Jan; 20(1):61-65. PubMed ID: 32504211
[TBL] [Abstract][Full Text] [Related]
16. Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin's lymphoma.
Mangano C; Ferrarini A; Forcato C; Garonzi M; Tononi P; Lanzellotto R; Raspadori A; Bolognesi C; Buson G; Medoro G; Hummel M; Fontana F; Manaresi N
Blood Cancer J; 2019 Nov; 9(12):92. PubMed ID: 31754095
[No Abstract] [Full Text] [Related]
17. Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives.
Cuceu C; Hempel WM; Sabatier L; Bosq J; Carde P; M'kacher R
Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29587466
[TBL] [Abstract][Full Text] [Related]
18. A method for identifying discriminative isoform-specific peptides for clinical proteomics application.
Zhang F; Chen JY
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):522. PubMed ID: 27557076
[TBL] [Abstract][Full Text] [Related]
19. RNA splicing: a new player in the DNA damage response.
Lenzken SC; Loffreda A; Barabino SM
Int J Cell Biol; 2013; 2013():153634. PubMed ID: 24159334
[TBL] [Abstract][Full Text] [Related]
20. Laser capture microdissection in the tissue biorepository.
Liu A
J Biomol Tech; 2010 Sep; 21(3):120-5. PubMed ID: 20808641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
